Cirtuvivint is a first-in-class CDC-like kinase (CLK) inhibitor.
Cirtuvivint is a first-in-class CDC-like kinase (CLK) inhibitor.
No indication information available.
No associated conditions information available.
Stay informed with timely notifications on clinical trials and research advancements.